IRIS
FAVOINO, ELVIRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.179
EU - Europa 1.985
AS - Asia 1.888
SA - Sud America 503
AF - Africa 89
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 8.649
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.112
RU - Federazione Russa 827
SG - Singapore 748
CN - Cina 434
BR - Brasile 403
IT - Italia 345
HK - Hong Kong 250
SE - Svezia 218
VN - Vietnam 153
DE - Germania 126
FR - Francia 119
FI - Finlandia 91
GB - Regno Unito 81
UA - Ucraina 79
IN - India 61
BD - Bangladesh 45
AR - Argentina 37
ID - Indonesia 36
TR - Turchia 31
CA - Canada 25
MX - Messico 22
PL - Polonia 20
ZA - Sudafrica 20
CI - Costa d'Avorio 18
IQ - Iraq 16
JP - Giappone 16
NL - Olanda 16
CO - Colombia 15
AT - Austria 14
BE - Belgio 14
PK - Pakistan 13
UZ - Uzbekistan 13
MY - Malesia 12
CL - Cile 11
EC - Ecuador 11
TN - Tunisia 10
ES - Italia 9
DZ - Algeria 8
PH - Filippine 8
PY - Paraguay 7
SA - Arabia Saudita 7
VE - Venezuela 7
EG - Egitto 6
IE - Irlanda 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
JO - Giordania 5
PE - Perù 5
TH - Thailandia 5
UY - Uruguay 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
KE - Kenya 4
LT - Lituania 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
HR - Croazia 3
IL - Israele 3
PA - Panama 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AO - Angola 2
BB - Barbados 2
BO - Bolivia 2
BW - Botswana 2
CG - Congo 2
EE - Estonia 2
GE - Georgia 2
KR - Corea 2
LB - Libano 2
NP - Nepal 2
PS - Palestinian Territory 2
ZW - Zimbabwe 2
AM - Armenia 1
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BZ - Belize 1
CH - Svizzera 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
NG - Nigeria 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
Totale 8.644
Salva come PNG Salva come JPEG
Città #
Ashburn 429
Fairfield 421
Singapore 381
Chandler 311
Woodbridge 263
Houston 251
Hong Kong 250
Bari 210
Jacksonville 208
Ann Arbor 189
Nyköping 186
Cambridge 184
Seattle 180
San Jose 169
Wilmington 167
Beijing 131
Nanjing 72
Lauterbourg 69
Roxbury 63
Lawrence 60
New York 57
Boardman 49
Los Angeles 48
Dallas 45
Des Moines 42
Ho Chi Minh City 42
Princeton 36
Helsinki 34
Inglewood 34
Hanoi 29
Moscow 27
São Paulo 24
Dearborn 23
Jakarta 21
London 21
Buffalo 20
Pune 20
Santa Clara 20
Falkenstein 19
Shenyang 19
Abidjan 18
Brooklyn 18
Warsaw 18
Council Bluffs 17
Orem 17
Frankfurt am Main 16
Munich 16
Paris 16
San Diego 16
Tokyo 16
Belo Horizonte 14
Chicago 14
Dong Ket 14
Rio de Janeiro 14
Brussels 13
Haiphong 13
Noicattaro 13
Tashkent 13
Atlanta 11
Chennai 11
Guangzhou 11
Montreal 11
Nanchang 11
Amsterdam 10
Nuremberg 10
San Francisco 10
Tianjin 10
Boston 9
Hebei 9
Rome 9
Ankara 8
Johannesburg 8
Mexico City 8
The Dalles 8
Vienna 8
Changsha 7
Denver 7
Poplar 7
Stockholm 7
Dublin 6
Fortaleza 6
Indiana 6
Jiaxing 6
Kuala Lumpur 6
Medellín 6
Shanghai 6
Turin 6
Auburn Hills 5
Buenos Aires 5
Campinas 5
Cape Town 5
Columbus 5
Curitiba 5
Dhaka 5
Kunming 5
Lima 5
Marseille 5
Porto Alegre 5
Quito 5
São José dos Campos 5
Totale 5.403
Salva come PNG Salva come JPEG
Nome #
Response to "Is active acid sphingomyelinase required for the antiproliferative response to rituximab?" [e-letter]. http://bloodjournal.hematologylibrary.org/content/117/13/3695.citation/reply#bloodjournal_el_2268 755
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association 204
ANTIBODIES TO ENDOPLASMIN AND THEIR USE 195
Methods for treating a tumor using an antibody that specifically binds HMW-MAA 186
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading 186
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis 180
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 176
Autoantibodies Recognizing the Amino Terminal 1-17 Segment of CENP-A Display Unique Specificities in Systemic Sclerosis 170
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 168
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases 162
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension 152
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease 151
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 147
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. 145
CD20 mimicry by a mAb rituximab-specific linear peptide: A potential tool for active immunotherapy of autoimmune diseases 142
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 136
Abstract 4390: Heat shock protein (HSP) Grp94-targeted combinatorial immunotherapy for pancreatic cancer 132
CD20: A target antigen for immunotherapy of autoimmune diseases 131
Effects of Adjuvants for Human Use in Systemic Lupus Erythematosus (Sle)-Prone (Nzb/Nzw) F1 Mice 129
Rheumatic disorders as paraneoplastic syndromes 128
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 127
CD20 mimicry by mAb Rituximab-specific linear peptide. A potential tool for active immunotherapy of autoimmune diseases 124
Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor 122
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease 120
The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells 117
Identification of an antigenic and immunogenic motif expressed by two 7-Mer Rituximab-specific cyclic peptides 112
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 111
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment 111
Dietary cholesterol supplementation and inhibitory factor 1 serum levels in two dizygotic Smith-Lemli-Opitz syndrome twins: a case report 111
Novel combinatorial therapy for pancreatic adenocarcinoma 110
Antitumor activity of BRAF inhibitor and IFN×alpha; Combination in BRAF-mutant melanoma 109
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors 108
Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes 107
Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis. 106
Beta2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 105
CSPG4 in cancer: Multiple roles 103
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence 103
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 101
Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy, Cancer Initiating Cells and Disease Recurrence 101
Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: Implication for peptide-based active immunotherapy 95
Circulating Inhibitory Factor 1 levels in adult patients with Prader-Willi syndrome 95
Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4 92
Characterization of the specificity of the Human scFv W9 92
Targeting cancer initiating cells in pancreatic adenocarcinoma 91
Harnessing host innate immunity may combat acquired resistance to BRAFi 91
Endothelial cells in tumor microenvironment: insights and perspectives 90
HLA allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and/or arthritis not fulfilling ASAS criteria: Comparison with psoriatic and undifferentiated spondyloarthritis 90
Identificazione del peptide che mima l'epitopo localizzato sulla catena pesante HLA-I non associata alla beta 2-microglobulina, riconosciuto dall'anticorpo monoclonale HC-10 90
Raynaud’s phenomenon: from molecular pathogenesis to therapy 89
Human CD4 mimicry by anti-idiotypic monoclonal antibody 16D7 is based on a conformational epitope 83
Ruolo degli autoanticorpi nelle patologie autoimmuni 82
AUTO-ANTIBODIES TO THE AMINO TERMINAL SEGMENT (AMINOACID 1-17) OF CENP-A DISPLAY A UNIQUE SPECIFICITY IN SYSTEMIC SCLEROSIS AND ARE INDEPENDENTLY EXPRESSED FROM THOSE AGAINST CENP-B 81
Insight into the specificità of the anti-CD20 monclonal antibody Rituximab. 80
EXPRESSION OF THE TRANSCRIPTION FACTOR FORKHEAD BOX E3 (FOXE3) IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH SYSTEMIC SCLEROSIS 79
null 77
Metodo ELISA: dosaggio della catena pesante della molecola HLA non associata alla b2-microglobulina 75
EXPRESSION OF THE TRANSCRIPTION FACTOR FORKHEAD BOX E3 (FOXE3) IN MONOCYTES FROM PATIENTS WITH SYSTEMIC SCLEROSIS AND CORRELATION WITH THEIR SEROLOGICAL PROFILE 75
Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir 73
Phlegmonous abscess associated with etanercept therapy 72
Ruolo degli autoanticorpi nelle patologie autoimmuni 70
Peptidi che mimano l'antigene CD20: potenzialità terapeutiche nel lupus eritematoso sistemico 69
Functional characterization of peptides mimicking the CD20 epitope recognized by Rituximab 68
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 67
Poems syndrome with amyloidosis and calchyphylaxis.A case report 66
Identification of an antigenic and immunogenic motif expressed by two 7-Mer Rituximab-specific cyclic peptides. Journal of Immunology 66
Quantitative evaluation of anti-FOXE-3 Ab identifies a subset of anti-CENP positive systemic sclerosis patients who are less prone to develop active disease 65
Two structurally different peptides mimic a CD20 epitope recognized by rituximab 64
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 60
Generation of linear and cyclic peptides revealed a unique fine specificity of Rituximab and its possible cross-reactivity with an acid sphingomyelinase-like phosphodiesterasem 3B precursor 60
 Peptides highly specific to the variable region of TNF-ALFA-specific references licensed (RL) monoclonal antibodies (MAB), as potential tool to effectively assess similarity between biosimilars and the correspondig RL MAB 60
Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing Pieces 59
Impact of belimumab therapy on the quality of life in patients with systemic lupus erythematosus: A cohort study 55
Systemic sclerosis and primary biliary cholangitis share an antibody population with identical specificity 51
Mimotope peptides in the immunization against CD20: a promising approach to the therapy of autoimmune diseases 50
null 49
Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors 44
Methods for treating a tumor using an antibody that specifically binds grp94 41
Classic pyoderma gangrenosum 41
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 39
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 34
null 33
Functional characterization of peptides mimicking the CD-20 epitope recognized by Rituximab 29
β2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 27
Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma 22
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 21
Barriers to therapy adherence in a group of Italian patients with systemic lupus erythematosus 12
Totale 8.897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.008
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021145 0 0 0 0 0 0 0 0 0 75 36 34
2021/2022522 24 67 6 18 22 34 51 22 32 23 97 126
2022/2023844 122 94 45 74 107 105 29 116 113 9 16 14
2023/2024363 24 53 19 70 21 77 11 21 8 8 6 45
2024/20251.280 79 18 114 20 28 86 158 106 53 67 178 373
2025/20263.207 396 159 181 374 307 170 354 93 934 239 0 0
Totale 8.897